Chemerin plays a protective role by regulating human umbilical vein endothelial cell-induced nitric oxide signaling in preeclampsia

Endocrine

Volumn 48, Issue 1, 2015, Pages 299-308

  Wang, Liqiong ^a   Yang, Tianli ^b   Ding, Yiling ^b   Zhong, Yan ^b   Yu, Ling ^b   Peng, Mei ^b  

^a THE UNIVERSITY OF HONG KONG SHENZHEN HOSPITAL   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Adipokine; Chemerin; Human umbilical vein endothelial cells; Nitric oxide; Preeclampsia

Indexed keywords

CHEMERIN PROTEIN, HUMAN; CHEMOKINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENZYME INHIBITOR; MESSENGER RNA; NITRIC OXIDE; ONCOPROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; SIGNAL PEPTIDE; TUMOR NECROSIS FACTOR;

ADULT; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; FEMALE; GENETICS; HUMAN; METABOLISM; PLACENTA; PREECLAMPSIA; PREGNANCY; SIGNAL TRANSDUCTION; UMBILICAL VEIN ENDOTHELIAL CELL;

ADULT; CHEMOKINES; ENZYME INHIBITORS; FEMALE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; ONCOGENE PROTEIN V-AKT; PHOSPHATIDYLINOSITOL 3-KINASES; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; RNA, MESSENGER; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84939885769     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-014-0286-y     Document Type: Article

References (30)

1. M.D. Lindheimer, S.J. Taler, F.G. Cunningham, Hypertension in pregnancy. J. Am. Soc. Hypertens. 4, 68–78 (2010)
2. M.M. Hedderson, A. Ferrara, High blood pressure before and during early pregnancy is associated with an increased risk of gestational diabetes mellitus. Diabetes Care 31, 2362–2367 (2008)
3. B. Dai, T. Liu, B. Zhang, X. Zhang, Z. Wang, The polymorphism for endothelial nitric oxide synthase gene, the level of nitric oxide and the risk for pre-eclampsia: a meta-analysis. Gene 519, 187–193 (2013)
4. M. Perlik, A. Seremak-Mrozikiewicz, M. Barlik, G. Kurzawinska, W. Krasnik, K. Drews, Genetic variants of endothelial nitric synthase in gestational hypertension and preeclampsia. Ginekol. Pol. 83, 652–659 (2012)
5. K.B. Goralski, T.C. McCarthy, E.A. Hanniman, B.A. Zabel, E.C. Butcher, S.D. Parlee, S. Muruganandan, C.J. Sinal, Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism. J. Biol. Chem. 282, 28175–28188 (2007)
6. S.J. Allen, B.A. Zabel, J. Kirkpatrick, E.C. Butcher, D. Nietlispach, T.M. Handel, NMR assignment of human chemerin, a novel chemoattractant. Biomol. NMR Assign. 1, 171–173 (2007)
7. V. Wittamer, J.D. Franssen, M. Vulcano, J.F. Mirjolet, E. Le Poul, I. Migeotte, S. Brezillon, R. Tyldesley, C. Blanpain, M. Detheux, A. Mantovani, S. Sozzani, G. Vassart, M. Parmentier, D. Communi, Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids. J. Exp. Med. 198, 977–985 (2003)
8. J.L. Cash, R. Hart, A. Russ, J.P. Dixon, W.H. Colledge, J. Doran, A.G. Hendrick, M.B. Carlton, D.R. Greaves, Synthetic chemerin-derived peptides suppress inflammation through ChemR23. J. Exp. Med. 205, 767–775 (2008)
9. S. Luangsay, V. Wittamer, B. Bondue, O. De Henau, L. Rouger, M. Brait, J.D. Franssen, P. de Nadai, F. Huaux, M. Parmentier, Mouse ChemR23 is expressed in dendritic cell subsets and macrophages, and mediates an anti-inflammatory activity of chemerin in a lung disease model. J. Immunol. 183, 6489–6499 (2009)
10. S.G. Roh, S.H. Song, K.C. Choi, K. Katoh, V. Wittamer, M. Parmentier, S. Sasaki, Chemerin: a new adipokine that modulates adipogenesis via its own receptor. Biochem. Biophys. Res. Commun. 362, 1013–1018 (2007)
11. M. Takahashi, Y. Takahashi, K. Takahashi, F.N. Zolotaryov, K.S. Hong, R. Kitazawa, K. Iida, Y. Okimura, H. Kaji, S. Kitazawa, M. Kasuga, K. Chihara, Chemerin enhances insulin signaling and potentiates insulin-stimulated glucose uptake in 3T3-L1 adipocytes. FEBS Lett. 582, 573–578 (2008)
12. H. Sell, J. Laurencikiene, A. Taube, K. Eckardt, A. Cramer, A. Horrighs, P. Arner, J. Eckel, Chemerin is a novel adipocyte-derived factor inducing insulin resistance in primary human skeletal muscle cells. Diabetes 58, 2731–2740 (2009)
13. Q. Yan, Y. Zhang, J. Hong, W. Gu, M. Dai, J. Shi, Y. Zhai, W. Wang, X. Li, G. Ning, The association of serum chemerin level with risk of coronary artery disease in Chinese adults. Endocrine 41, 281–288 (2012)
14. M. Yang, G. Yang, J. Dong, Y. Liu, H. Zong, H. Liu, G. Boden, L. Li, Elevated plasma levels of chemerin in newly diagnosed type 2 diabetes mellitus with hypertension. J. Investig. Med. 58, 883–886 (2010)
15. A.A. Roman, S.D. Parlee, C.J. Sinal, Chemerin: a potential endocrine link between obesity and type 2 diabetes. Endocrine 42, 243–251 (2012)
16. Y.J. Hah, N.K. Kim, M.K. Kim, H.S. Kim, S.H. Hur, H.J. Yoon, Y.N. Kim, K.G. Park, Relationship between chemerin levels and cardiometabolic parameters and degree of coronary stenosis in Korean patients with coronary artery disease. Diabetes Metab. J. 35, 248–254 (2011)
17. C. Ress, A. Tschoner, J. Engl, A. Klaus, H. Tilg, C.F. Ebenbichler, J.R. Patsch, S. Kaser, Effect of bariatric surgery on circulating chemerin levels. Eur. J. Clin. Invest. 40, 277–280 (2010)
18. T. Stefanov, M. Bluher, A. Vekova, I. Bonova, S. Tzvetkov, D. Kurktschiev, T. Temelkova-Kurktschiev, Circulating chemerin decreases in response to a combined strength and endurance training. Endocrine 45(3), 382–391 (2014)
19. D.M. Duan, J.M. Niu, Q. Lei, X.H. Lin, X. Chen, Serum levels of the adipokine chemerin in preeclampsia. J. Perinat. Med. 40, 121–127 (2012)
20. H. Stepan, A. Philipp, I. Roth, S. Kralisch, A. Jank, W. Schaarschmidt, U. Lossner, J. Kratzsch, M. Bluher, M. Stumvoll, M. Fasshauer, Serum levels of the adipokine chemerin are increased in preeclampsia during and 6 months after pregnancy. Regul. Pept. 168, 69–72 (2011)
21. C. Popa, M.G. Netea, P.L. van Riel, J.W. van der Meer, A.F. Stalenhoef, The role of TNF-alpha in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk. J. Lipid Res. 48, 751–762 (2007)
22. A. Var, Y. Yildirim, E. Onur, N.K. Kuscu, B.S. Uyanik, K. Goktalay, Y. Guvenc, Endothelial dysfunction in preeclampsia: increased homocysteine and decreased nitric oxide levels. Gynecol. Obstet. Invest. 56, 221–224 (2003)
23. C.T. Minson, L.A. Holowatz, B.J. Wong, W.L. Kenney, W.L. Kenney, B.W. Wilkins, Decreased nitric oxide- and axon reflex-mediated cutaneous vasodilation with age during local heating. J. Appl. Physiol. 93, 1644–1649 (2002)
24. C.F. Mang, S. Truempler, D. Erbelding, H. Kilbinger, Modulation by NO of acetylcholine release in the ileum of wild-type and NOS gene knockout mice. Am. J. Physiol. Gastrointest. Liver Physiol. 283, G1132–G1138 (2002)
25. H. Yamawaki, S. Kameshima, T. Usui, M. Okada, Y. Hara, A novel adipocytokine, chemerin exerts anti-inflammatory roles in human vascular endothelial cells. Biochem. Biophys. Res. Commun. 423, 152–157 (2012)
26. J. Kaur, R. Adya, B.K. Tan, J. Chen, H.S. Randeva, Identification of chemerin receptor (ChemR23) in human endothelial cells: chemerin-induced endothelial angiogenesis. Biochem. Biophys. Res. Commun. 391, 1762–1768 (2010)
27. C.F. Mang, S. Truempler, D. Erbelding, H. Kilbinger, Modulation by NO of acetylcholine release in the ileum of wild-type and NOS gene knockout mice. Am. J. Physiol. Gastrointest. Liver Physiol. 283, G1132–G1138 (2002)
28. K. Osuka, Y. Watanabe, N. Usuda, K. Atsuzawa, J. Yoshida, M. Takayasu, Modification of endothelial nitric oxide synthase through AMPK after experimental subarachnoid hemorrhage. J. Neurotrauma 26, 1157–1165 (2009)
29. C. Stirone, A. Boroujerdi, S.P. Duckles, D.N. Krause, Estrogen receptor activation of phosphoinositide-3 kinase, akt, and nitric oxide signaling in cerebral blood vessels: rapid and long-term effects. Mol. Pharmacol. 67, 105–113 (2005)
30. M.M. Herenius, A.S. Oliveira, C.A. Wijbrandts, D.M. Gerlag, P.P. Tak, M.C. Lebre, Anti-TNF therapy reduces serum levels of chemerin in rheumatoid arthritis: a new mechanism by which anti-TNF might reduce inflammation. PLoS One 8, e57802 (2013)